Literature DB >> 23371338

Gorham-Stout disease and generalized lymphatic anomaly--clinical, radiologic, and histologic differentiation.

Shailee Lala1, John B Mulliken, Ahmad I Alomari, Steven J Fishman, Harry P Kozakewich, Gulraiz Chaudry.   

Abstract

PURPOSE: Gorham-Stout disease (GSD) is a rare vascular disorder of lymphatic origin characterized by progressive osteolysis. Generalized lymphatic anomaly (GLA) is a multisystem disorder that also commonly affects bone. We hypothesized that Gorham-Stout disease is different from other osseous lymphatic anomalies. We proposed to discriminate these entities by analyzing findings on skeletal imaging.
METHODS: Clinical data, imaging studies, and histopathologic findings were retrospectively reviewed in patients presenting to our Vascular Anomalies Center with lymphatic anomalies of bone.
FINDINGS: Within a cohort of 51 patients with lymphatic disorder and radiological evidence of bony involvement, two distinct categories emerged. Nineteen patients met the imaging criteria for GSD: progressive osteolysis with resorption and cortical loss. Thirty-two were categorized as GLA: Discrete radiolucencies and increasing numbers of bone affected over time, but without evidence of progressive osteolysis. The ribs were the most common site in both groups, followed by the cranium, clavicle, and cervical spine in GSD, and thoracic spine, humerus, and femur in GLA. Fewer bones were involved in GSD, with relative sparing of the appendicular skeleton. Associated infiltrative soft tissue abnormality was seen in 18 in GSD, but only six with GLA. Macrocystic lymphatic malformations were identified in 14 with GLA, but none with GSD.
CONCLUSIONS: There are significant radiological differences between GSD and GLA, although there are some overlapping features. The major distinguishing characteristic is the progressive osteolysis seen in GSD. Findings suggestive of GLA are more extensive involvement, particularly of the appendicular skeleton, presence of discretemacrocystic lymphatic malformations and visceral organ lesions.

Entities:  

Mesh:

Year:  2013        PMID: 23371338     DOI: 10.1007/s00256-012-1565-4

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  15 in total

1.  Chylothorax complicating Gorham's disease.

Authors:  N Chavanis; P Chaffanjon; G Frey; G Vottero; P Y Brichon
Journal:  Ann Thorac Surg       Date:  2001-09       Impact factor: 4.330

2.  Observations on massive osteolysis; a review of the literature and report of a case.

Authors:  P M JOHNSON; J G McCLURE
Journal:  Radiology       Date:  1958-07       Impact factor: 11.105

3.  Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis.

Authors:  L W GORHAM; A P STOUT
Journal:  J Bone Joint Surg Am       Date:  1955-10       Impact factor: 5.284

4.  CT and MR imaging of generalized cystic lymphangiomatosis in pediatric patients.

Authors:  P Wunderbaldinger; K Paya; B Partik; K Turetschek; M Hörmann; E Horcher; A A Bankier
Journal:  AJR Am J Roentgenol       Date:  2000-03       Impact factor: 3.959

Review 5.  Gorham disease of bone: three cases and review of radiological features.

Authors:  B Kai; A Ryan; P L Munk; P Dunlop
Journal:  Clin Radiol       Date:  2006-12       Impact factor: 2.350

6.  CT and MRI of massive osteolysis of Gorham.

Authors:  J Assoun; G Richardi; J J Railhac; P Le Guennec; M Caulier; C Dromer; L Sixou; B Fournie; M Mansat; D Durroux
Journal:  J Comput Assist Tomogr       Date:  1994 Nov-Dec       Impact factor: 1.826

7.  Cutaneous lymphatic malformations in disappearing bone (Gorham-Stout) disease: a novel clue to the pathogenesis of a rare syndrome.

Authors:  Daniela Bruch-Gerharz; Claus-Dieter Gerharz; Helger Stege; Jean Krutmann; Michael Pohl; Rainer Koester; Thomas Ruzicka
Journal:  J Am Acad Dermatol       Date:  2006-09-14       Impact factor: 11.527

Review 8.  CT and MRI of Gorham syndrome.

Authors:  P Vinée; M O Tanyü; K H Hauenstein; G Sigmund; B Stöver; C P Adler
Journal:  J Comput Assist Tomogr       Date:  1994 Nov-Dec       Impact factor: 1.826

Review 9.  Gorham's disease: an osseous disease of lymphangiogenesis?

Authors:  Kavita Radhakrishnan; Stanley G Rockson
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

10.  Gorham-Stout disease--stabilization during bisphosphonate treatment.

Authors:  Fabian Hammer; Werner Kenn; Ulrich Wesselmann; Lorenz C Hofbauer; Günter Delling; Bruno Allolio; Wiebke Arlt
Journal:  J Bone Miner Res       Date:  2004-11-16       Impact factor: 6.741

View more
  45 in total

1.  Imaging features of kaposiform lymphangiomatosis.

Authors:  Pradeep Goyal; Ahmad I Alomari; Harry P Kozakewich; Cameron C Trenor; Antonio R Perez-Atayde; Steven J Fishman; Arin K Greene; Raja Shaikh; Gulraiz Chaudry
Journal:  Pediatr Radiol       Date:  2016-04-06

2.  Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.

Authors:  Kiersten W Ricci; Adrienne M Hammill; Paula Mobberley-Schuman; Stephen C Nelson; Julie Blatt; Julia L Glade Bender; Catherine C McCuaig; Anna Synakiewicz; Ilona J Frieden; Denise M Adams
Journal:  Pediatr Blood Cancer       Date:  2019-01-22       Impact factor: 3.167

3.  Case Report: Gorham-Stoute Syndrome with Involvement of Majority of Mandible, and Partial Maxillary, Temporal and Zygomatic Bones.

Authors:  Mustafa Kürşat Evrenos; Merve Özkaya; Murat Yaman; Levent Yoleri Proff
Journal:  J Maxillofac Oral Surg       Date:  2015-12-08

4.  Thoracic osteotomy for Gorham-Stout disease of the spine: a case report and literature review.

Authors:  C Maillot; T Cloche; J-C Le Huec
Journal:  Eur Spine J       Date:  2014-10-21       Impact factor: 3.134

Review 5.  Vascular anomalies: A pictorial review of nomenclature, diagnosis and treatment.

Authors:  John L Nosher; Philip G Murillo; Mark Liszewski; Vyacheslav Gendel; Christopher E Gribbin
Journal:  World J Radiol       Date:  2014-09-28

6.  Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly.

Authors:  Stacy E Croteau; Harry P W Kozakewich; Antonio R Perez-Atayde; Steven J Fishman; Ahmad I Alomari; Gulraiz Chaudry; John B Mulliken; Cameron C Trenor
Journal:  J Pediatr       Date:  2013-11-16       Impact factor: 4.406

7.  Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly.

Authors:  Dong Li; Tara L Wenger; Christoph Seiler; Michael E March; Alvaro Gutierrez-Uzquiza; Charlly Kao; Elizabeth Bhoj; Lifeng Tian; Misha Rosenbach; Yichuan Liu; Nora Robinson; Mechenzie Behr; Rosetta Chiavacci; Cuiping Hou; Tiancheng Wang; Marina Bakay; Renata Pellegrino da Silva; Jonathan A Perkins; Patrick Sleiman; Michael A Levine; Patricia J Hicks; Maxim Itkin; Yoav Dori; Hakon Hakonarson
Journal:  Hum Mol Genet       Date:  2018-09-15       Impact factor: 6.150

8.  Initial Experience With Propranolol Treatment of Lymphatic Anomalies: A Case Series.

Authors:  June K Wu; Ellen D Hooper; Sherelle L Laifer-Narin; Lynn L Simpson; Jessica Kandel; Carrie J Shawber
Journal:  Pediatrics       Date:  2016-08-25       Impact factor: 7.124

9.  Craniofacial CT findings of Gorham-Stout disease and generalized lymphatic anomaly.

Authors:  Hiroki Kato; Michio Ozeki; Toshiyuki Fukao; Masayuki Matsuo
Journal:  Neuroradiology       Date:  2016-04-28       Impact factor: 2.804

10.  Lymphatics in bone arise from pre-existing lymphatics.

Authors:  Marco Monroy; Anna L McCarter; Devon Hominick; Nina Cassidy; Michael T Dellinger
Journal:  Development       Date:  2020-04-20       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.